ORTH ANDREW C.
Insider CIK 1860010 · KRYS Chief Commercial Officer · CTY President & CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CTY CITY THERAPEUTICS, INC. | A Award deriv | 2026-10-19 | 2026-10-19 | 77,979 | — | $0 | 77,979 | SEC↗ |
| KRYS Krystal Biotech, Inc. | M Exercise deriv | 2023-06-09 | 2023-06-09 | 12,500 | — | $0 | 37,500 | SEC↗ |
| KRYS Krystal Biotech, Inc. | S Sale | 2023-06-09 | 2023-06-09 | 5,261 | $128.10 | $673.9K | 7,339 | SEC↗ |
| KRYS Krystal Biotech, Inc. | S Sale | 2023-06-09 | 2023-06-09 | 333 | $129.70 | $43.2K | 100 | SEC↗ |
| KRYS Krystal Biotech, Inc. | S Sale | 2023-06-09 | 2023-06-09 | 6,906 | $128.94 | $890.5K | 433 | SEC↗ |
| KRYS Krystal Biotech, Inc. | M Exercise | 2023-06-09 | 2023-06-09 | 12,500 | $63.55 | $794.4K | 12,600 | SEC↗ |
| KRYS Krystal Biotech, Inc. | A Award deriv | 2023-02-28 | 2023-02-28 | 20,000 | — | $0 | 20,000 | SEC↗ |
| KRYS Krystal Biotech, Inc. | A Award deriv | 2023-02-28 | 2023-02-28 | 10,000 | — | $0 | 10,000 | SEC↗ |
| KRYS Krystal Biotech, Inc. | A Award deriv | 2022-02-28 | 2022-03-01 | 50,000 | — | $0 | 50,000 | SEC↗ |
| KRYS Krystal Biotech, Inc. | A Award deriv | 2021-05-31 | 2021-06-02 | 205,000 | — | $0 | 205,000 | SEC↗ |